NanoViricides' drug pipeline to be discussed at NanoBusiness2009

Download PDF Copy

Sep 8 2009

NewsGuard 100/100 Score

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been asked to present a talk at NanoBusiness2009 - the 8th annual NanoBusiness Conference.

Dr. Diwan will speak about the nanoviricides™ drug pipeline, including Influenza (FluCide™), HIV (HIVCide™), antiviral eye-drops (EKCCide™) and the newly initiated Herpes “cold sores” and genital herpes preclinical stage program. He will speak about how the nanoviricides technology platform has enabled rapid drug development against a number of diseases caused by many different viruses. Dr. Diwan will speak in the session entitled “New Pharmaceutical Compounds Based on Soft Nanotechnology: Novel Classes of Therapeutics” on Wednesday, September 9. The Conference is being held at the McCormick Place, Chicago, IL.

http://www.nanoviricides.com/

Posted in: Medical Science News | Pharmaceutical News

Tags: Bird Flu, Cold, Cold Sores, Eye, Genital Herpes, H1N1, H5N1, Hepatitis C, Herpes, HIV, HIV/AIDS, HIV-1, Influenza, Nanotechnology, Pharmaceuticals, Preclinical, Swine Flu, Technology, Therapeutics, Virus

Comments (0)

Download PDF Copy

Suggested Reading

Unraveling the mystery of viral evolution

Unraveling the mystery of viral evolution

Rising syphilis cases highlight gaps in public knowledge on symptoms and treatment

Rising syphilis cases highlight gaps in public knowledge on symptoms and treatment

New insights into pain mechanisms related to viral infections

New insights into pain mechanisms related to viral infections

APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

A review of clinical features, diagnosis, and management of Mpox

A review of clinical features, diagnosis, and management of Mpox

Recombinant shingles vaccination found to lower dementia risk

Recombinant shingles vaccination found to lower dementia risk

First global estimates of economic costs of genital herpes infections

First global estimates of economic costs of genital herpes infections

Long-term low-dose antiviral treatment reduces eye disease risk from shingles

Long-term low-dose antiviral treatment reduces eye disease risk from shingles

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Recombinant shingles vaccine linked to lower dementia risk, especially in women